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Abstract
Background: Lead exposure remains a public health concern due to its serious adverse effects, such as cognitive
and behavioral impairment: children younger than six years of age being the most vulnerable population. In
Europe, the lead-related economic impacts have not been examined in detail. We estimate the annual costs in
France due to childhood exposure and, through a cost benefit analysis (CBA), aim to assess the expected social
and economic benefits of exposure abatement.
Methods: Monetary benefits were assessed in terms of avoided national costs. We used results from a 2008 survey
on blood-lead (B-Pb) concentrations in French children aged one to six years old. Given the absence of a threshold
concentration being established, we performed a sensitivity analysis assuming different hypothetical threshold
values for toxicity above 15 μg/L, 24 μg/L and 100 μg/L. Adverse health outcomes of lead exposure were
translated into social burden and economic costs based on literature data from literature. Direct health benefits,
social benefits and intangible avoided costs were included. Costs of pollutant exposure control were partially
estimated in regard to homes lead-based paint decontamination, investments aiming at reducing industrial lead
emissions and removal of all lead drinking water pipes.
Results: The following overall annual benefits for the three hypothetical thresholds values in 2008 are: €22.72
billion, €10.72 billion and €0.44 billion, respectively. Costs from abatement ranged from €0.9 billion to 2.95
billion/year. Finally, from a partial CBA of lead control in soils and dust the estimates of total net benefits were
€ 3.78 billion, € 1.88 billion and €0.25 billion respectively for the three hypothesized B-Pb effect values.
Conclusions: Prevention of childhood lead exposure has a high social benefit, due to reduction of B-Pb
concentrations to levels below 15 μg/L or 24 μg/L, respectively. Reducing only exposures above 100 μg/L B-Pb has
little economic impact due to the small number of children who now exhibit such high exposure levels. Prudent
public policies would help avoiding future medical interventions, limit the need for special education and increase
future productivity, and hence lifetime income for children exposed to lead.
Background
Lead is a well known toxic metal, and current exposures
in children constitute a reason for concern [1]. In
France, lead has multiple anthropogenic sources and is
now mainly present in its inorganic form in the environ-
ment [2,3]. The relative importance of different sources
depends on the blood lead range. For the general
European population [1] and for children [4], food is
usually the major source of exposure, with cereals and
vegetables products contributing mostly to dietary lead
exposure. Tap water can also, in some cases, be an
important contributor because of the presence of lead
pipes in old homes and public plumbing systems. Degra-
dation of old lead-based paint results in the contamina-
tion of indoor dust that can be inhaled or ingested, thus
adding to the sources already mentioned. Other inciden-
tal sources of lead exposure include consumer products,
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notably toys, and hobbies or occupations involving lead
[3]. After the ban of leaded petrol, air concentrations
have decreased substantially and are now due almost
entirely to industrial emissions [5,6]. In France, the tar-
geted regulations to decrease elevated B-Pb concentra-
tions, control measures and screening strategies have
progressively reduced risks from lead pipes, lead-based
paint in houses built before 1949 and contamination at
specific industrial sites [3]. Children under six years of
age have the highest exposure to lead because of several
factors such as greater hand dust contamination, fre-
quent hand-to-mouth transfer and higher absorption
rates than adults. Also, lead can pass through the pla-
centa so that the child is born with lead from the
mother’s cumulated body burden [7]. Overall, lead poi-
soning is still a serious hazard for children and causes
significant neurologic damage linked to cognitive and
behavioral impairment [1,8]. Although frequently over-
looked, the timing of the dose in regard to windows of
highest vulnerability in children is also important [9,10].
The first national study carried out in France in 1999
by the National Institute of Health and Medical
Research (INSERM) showed that 2% of French children
aged one to six years of age had B-Pb concentrations
> 100 μg/L (i.e. approximately 85,000 children); the geo-
metric mean blood-lead concentration was 37 μg/L [2].
This exposure level was similar to other Western Eur-
opean countries [11]. In a new survey, 2008-2009, the
National Institute for Health Surveillance (InVS) [12]
found that the geometric mean B-Pb had decreased to
15 μg/L (standard deviation [SD], 1.6) among children
aged 1-6 years, and the prevalence of B-Pb concentra-
tions > 100 μg/L had dwindled to 0.11% (i.e. 5,333 chil-
dren) [12]. Nonetheless, many children are still at risk
because there is no evidence for a lead toxicity thresh-
old. The B-Pb concentration intervention value in the
US and France is 100 μg/L; above this limit the subject
is considered as lead poisoning by public health authori-
ties and is supposed to be reported in the French
National system of surveillance of children’s B-Pb con-
centrations. At lower values lead toxicity may still cause
damage to nervous system functions, including
decreased nerve conduction velocity and cognitive defi-
cits [1], and significant neurologic damage may occur as
a result of both intrauterine and postnatal exposures
[13,14]. The intellectual decrement may be expressed in
terms of a loss of IQ points for every μg/L unit increase
of the B-Pb, but this loss slope is steeper at B-Pb con-
centrations lower than 100 μg/L than at higher levels
[14]. At the individual level, this drop may seem small
and inconsequential, but at the population level, small
effects in many individuals are likely to have an impact
on the overall societal benefits [11]. The effects include
lower school performance and educational attainment,
which may influence societal adaptation and economic
success, with some affected children showing juvenile
delinquency [11,15]. Therefore, improvements in cogni-
tive ability will benefit society by raising both economic
wealth and overall wellbeing. Several economic studies,
mainly in the US, have estimated the costs and risks
associated with infantile lead poisoning and lead toxicity,
in some cases weighing them against the costs asso-
ciated with lead-based paint control and other efforts.
These studies have also calculated the potential
increased financial earnings that would result if the level
of lead in children’s blood were to be reduced [[8,16],
and [17]]. In France, studies are mostly epidemiological,
focusing on targeted screening and lead exposure. There
have been few economic assessments of lead’s impact
on the children’s health, with the exception of the stu-
dies by Chanel [18-20], while Fassin and colleagues
highlighted the social aspects of lead exposure [21]. The
present paper aims to fill the gap and contribute at least
in part to a cost benefit analysis (CBA), while taking
into account that there is “no single estimate that accu-
rately reflects the costs and the benefits of lead hazard
control” [8]. We first summarize the childhood lead
exposure situation in France and related information on
the main exposure media and risk factors. We then esti-
mate the monetary benefits that can be expected from
pollutant abatement, with estimates of investment costs
to achieve this reduction, as based on available informa-
tion. Lastly, we compare the main findings of this study
and discuss the role of CBA in a societal perspective of
public policy development.
Methods
Population studied and sources of lead exposure
We based our estimations on the InVS study [12]. The
geometric mean of children’s B-Pb concentrations in
France was found to be 15.1 μg/L, with a SD of 1.6 (log-
normal distribution). We used the same target popula-
tion consisting of 4.7 million children from one to six
years of age according to the National Institute for
Statistics and Studies [12]. Table 1 shows the distribution
and the number of children exceeding the hypothetical
threshold values for this cohort. Estimates were made
based on the entire cohort in order to highlight the global
economic impact on the most sensitive segment of the
population to lead exposure. Derived from this estimate,
the size of the population experiencing lead poisoning (at
B-Pb ≥100 μg/L) was 5,333 [12]. We used data from the
French National system of surveillance of children’s B-Pb
concentrations (SNSPE, 2005-2007) [22] to assess the
distribution of risk factors among children with B-Pb
concentrations ≥ 100 μg/L. Based on the SNSPE data,
74% of the cases were associated with poor housing: old
buildings (i.e. those built before 1949), degraded, with
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humidity and lead-based paint still present on walls or
windows and door frames. Another 4% were estimated to
be linked to industrial emissions and only 1% to contami-
nated water. However, it is worth noting that these data
rely upon screening programmes whose results may vary
according to the main sources of exposure in different
regions, and also according to the screening strategy. For
example, in the Paris region, the main exposure media for
high (≥100 μg/L) B-Pb concentrations were contaminated
dust and soils. In comparison, exposure of the screened
children in the North of France region was mainly linked
to the old Metaleurop smelter which represented 42% of
all screened cases. Based on these same data, all regions
included, we thus considered that contaminated soils and
dust or ingested flakes from degraded paint in old homes
<1949 were the main risk factor in three out of four cases
for B-Pb concentrations ≥ 100 μg/L. These results are in
line with US data where 70% of cases with high B-Pb
concentrations were due to lead-based paint [23].
Now, 99% of children from one to six years old have
B-Pb concentrations <100 μg/L (Table 1). Glorennec
and colleagues [4] estimated the fractions of exposure
due to different sources for this population under ordin-
ary exposure conditions. We selected these data to
assess the contribution of the most prominent risk fac-
tors at the 75th percentile of the distribution (P75). Food
was found to constitute the main exposure medium
(83%), followed by dust and soil (16%) and water (1%).
Assessment of IQ decrements
Environmental lead exposure in children may cause cog-
nitive impairment among children ≤ 6 years, as assessed
by measurement of IQ. The international pooled analy-
sis by Lanphear and colleagues [14] established a non-
linear, negative relationship between IQ and B-Pb con-
centrations. Between 24 and 100 μg/L, the decrement
per unit of μg/L increase in B-Pb amounted to 3.9 IQ
points (95% CI, 2.4-5.3). At higher exposures, i.e. from
to 100 to 200 μg/L, and from 200 to 300 μg/L, the drop
in IQ points was 1.9 (95% CI, 1.2-2.6), and 1.1 (95% CI,
0.7-1.5), respectively. Thus far, there are few studies so
far examining exposures below 24 μg/L. However, as
concluded by the European Food Authority Safety
(EFSA): “no threshold for these effects has been identi-
fied, and the evidence suggests that the response at B-Pb
concentrations below 100 μg/L is steeper than at higher
exposure levels” [1]. In addition, a recent risk assessment
study by the California Environmental Protection Agency
(CEPA) calculated that a 10-μg/L increase in B-Pb in the
range of 10-100 μg/L resulted in a population-level
decrement of one IQ point [24,25].
Given that no threshold for lead toxicity has been estab-
lished, we conducted a sensitivity analysis assuming that
loss of IQ in the study population starts at values exceed-
ing 15 μg/L, respectively 24 and 100, following a “what if
?” approach; the first value is close to the geometric mean
of B-Pb among French children (15.1 μg/L) [12]. We
assumed a loss of one IQ point from 15 to 24 μg/L. And
further used the dose-effect decrements calculated by Lan-
phear and colleagues for values from 24 to 100 μg/L, and
a loss of 1.9 IQ points from 100 μg/L to 200 ug/L.
Cost Benefit Analysis
Cost benefit analysis (CBA) is often used in health care
assessment, as it links the costs of a strategy to its
results or benefits expressed in monetary units. The
rationale of CBA implies that an intervention should be
undertaken if the sum of its benefits (B) is greater than
the sum of its costs (C). An alternative way of expres-
sing this is to say that its net benefit (B-C) is positive or
that its B/C ratio is greater than 1. The preferred option
will be the one which maximizes this net benefit, and
consequently the new CBA-based health strategy will
provide a net benefit to society [26-28].
For this study, we based our estimation on the yearly
economic impact of reduction of lead exposure for each
birth cohort (children born within one calendar year) and
compared these social benefits to investments needed to
reduce exposure and control risk factors. Because little
information is available on the investments required in
France to abate lead exposure, we focused our evaluation
on the benefit side, and provided preliminary estimates
of costs of exposure abatement. We assessed the benefits
in terms of avoided costs (see Figure 1).
The calculation of benefits took into account the
range of B-Pb concentrations above the thresholds
Table 1 Estimates of total direct health costs within B-Pb concentration ranges for the French child population (€2008)
Blood-lead concentrations range (μg/L) % of children aged 1 to 6 yearsa Number of childrena Unit cost (€) Total costs (€ million)
B-Pb < 15 50.00 2,348,091 0 0
15 ≤ B-Pb < 24 35.1 1,648,975 120 198
24 ≤ B-Pb < 100 14.8 693,783 120 83
B-Pb ≥ 100 0.1 5,333 2,932 16
a On the basis of INSEE data and INVS results, 2010.
Table 1 shows the direct health cost Bmed within B-Pb concentration ranges for the French child population. Bscreening 15-24 and Bscreening24-100 amount to 120 €
per child and Btreatment≥ 100 is estimated to €2,932 which equals to ((1,819*0.73+4,851*0.27) +294) per child.
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already defined. These estimates of benefits B are
defined as follows:
B = Bmed + [Bearn/w] + Bspec.ed + Bcrime + Bother (1)
where Bmed are the direct avoided costs; Bearn/w are
the lost lifetime earnings, applying a discount factor w
equal to (1+s) t, with a 3% discount rate (s) to a time
horizon t about 30 years; Bspec.ed are the costs for special
education; Bcrime are the costs due to juvenile delin-
quency - the latter three being social benefits; and Bother
are the intangible costs. For our estimations, we used
the purchasing parity power (GDPppp$-€) when apply-
ing American cost data in the French setting. The esti-
mates are inflation adjusted [26,29,30] and performed
for one year (2008).
Annual benefit estimation
Health benefits: costs of avoiding lead poisoning
Bmed = Bscreening15−24 + Bscreening24−100 + Btreatment100 (2)
Based on the InVS data B-Pb distribution (Table 1),
we estimated direct costs Bmed from the component
costs Bscreening15-24, Bscreening24-100 and Btreatment ≥ 100 for
screening and treatment within the observed B-Pb range
(15-24 μg/L as “15-24”, 24-100 μg/L as “24-100” and
≥ 100 μg/L as “≥ 100”, respectively). We calculated
Bscreening15-24, Bscreening24-100 and Btreatment ≥ 100 as costs
of screening, hospitalization, and medical consultations
within the observed B-Pb range and in agreement with
the French recommendations [31] for children aged six
months to six years. Part of these costs were based on a
pilot study undertaken by the Aubervilliers local authority,
which provided reference costs for 2006, that were infla-
tion-adjusted for 2008 [3]. B-Pb < 15 μg/L was considered
as not requiring medical attention. Since treatment is used
only for children above 100 μg/L, subjects with lower values
incur only screening costs which amount to 120 € per child
in 2008, labeled as Bscreening 15-24 and Bscreening24-100,
respectively. The direct health cost estimates for B-Pb ≥
100 μg/L up to 300 μg/L is given by Btreatment ≥ 100. In this
case, the screening cost per child was estimated from
€1,819 for screened children (73% of all cases) to
€4,851 for new cases of lead toxicity (27% of all cases
[3]). We also added unit costs for medical follow-up:
€294, medication included, according to Brown [32].
Unit cost estimate of outpatient chelation treatment,
without medication, was €3,491 of which €2,365 and
€1,126 for nursing follow-up and in-home hospitaliza-
tion, respectively. This cost should be added to screen-
ing costs for children with B-Pb concentrations
≥300 μg/L [33]. Hence, Btreatment ≥ 100, equal to €2,932
[(1,819*0.73+4,851*0.27) +294] for lead toxicity at B-Pb
≥ 100 μg/L, should be €6,423 (2,932+3,491) for B-Pb ≥
300 μg/L. However, due to the lack of information on
the number of children with B-Pb concentrations ≥300
μg/L in the InVS study, we assumed that all screening
costs were €2,932 for B-Pb ≥100 μg/L.
Indirect economic benefits related to health improvement
In our case, part of the indirect costs represents the pro-
ductivity losses to society due to lead toxicity. For the
purpose of this study, the indirect costs include the loss
of lifetime earnings, the costs of special education, and
the costs of juvenile delinquency.
IQ and lost lifetime earnings due to lead poisoning
The lifetime costs associated with lower earning poten-
tial caused by lead toxicity is based on a linear rela-
tionship between the loss of IQ due to lead and
expected lifetime earnings. From the studies by Lan-
phear and colleagues [14], and the CEPA study [24],
we assumed 1 IQ point loss from 15 to 24 μg/L.
According to Lanphear ’s IQ decrements, we used
3.9 IQ points from 24 to 100 μg/L, to which, we added
the first IQ point loss, (1+3.9 = 4.9). We applied an
average IQ point loss of 3.9/7.6 = 0.51 point per
10 μg/L within this range. According to the available
data in [12], we used percentile values for the
Avoided Health 
costs
Avoided Social 
costs
Lost life 
time 
earnings
Special 
education
Crime
Intangible 
costs : 
pretium 
doloris
Specific 
screening for 24
?B-Pb 
concentrations 
<100 ?g/L
Treatment for 
B-Pb 
concentrations 
?100 ?g/L
Figure 1 Monetary benefits assessed in terms of avoided costs.
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intermediate calculations between 24 and 100 μg/L.
Above 100 μg/L, the IQ point loss was 6.8 (= 1+3.9
+1.9) per 100 μg/L (Table 2). Although the IQ and the
B-Pb assessments were usually made at 7 years, similar
associations were found for lead concentrations at
younger ages, but they are considered less stable
[14,34]. We therefore applied these IQ losses to the
selected 1-6 years children. We followed Gould’s
method where estimates of IQ decrement were based
on the data from the main published studies
[16,17,35], and we drew from her 2006 estimate of
$2006 17,815 for the present value of incremental life-
time earnings. We adjusted it for inflation to €2008 and
the loss was thus estimated to be €17,363 per IQ point
in 2008. Again,
Bearn = Bearn15−24 + Bearn24−100 + Bearn100 (3)
where Bearn are the total lost lifetime earnings due to
lead toxicity, with Bearn15-24 for increased B-Pb < 24 μg/L,
Bearn24-100 for B-Pb from 24 μg/L to 100 μg/L, and
B Bearn≥ 100 for B-Pb ≥100 μg/L.
Special education
Children with elevated B-Pb concentrations have an
increased risk of enrollment in special education. Two
categories of French institutions take care of children
and young adults between three and 20 years old with
cognitive and behavioral impairment. The Medical Edu-
cational Institutes (IME) educates children with intellec-
tual deficiency symptoms while the Educational and
Therapeutic Institutes (ITEP) do so for behavioral pro-
blems. According to Schwartz [16], 20% of children with
B-Pb > 250 μg/L need special education. A more recent
study suggested that the need for such service could
start below this concentration [36], i.e. when B-Pb
exceeds 100 μg/L. Lyngbye and al. showed that, even at
low levels of lead exposure, the need for special educa-
tion increases with the exposure level [37]. Another
reference also showed for children with B-Pb≥100 μg/L
lower intelligence and behavior changes [38]. From their
findings, we estimated the need for special education to
be 10% for children with B-Pb ≥ 100 μg/L, the cost
denoted Bspec.ed≥ 100.
The French national data show that 79.8% and 20.1%
children with cognitive and behavioral deficiencies are
in IME and ITEP, respectively [39]. The estimated aver-
age annual cost per child was €38,958 in IME and
€48,255 in ITEP in 2008 [40].
Violent behavior leading to juvenile delinquency
The Nevin’s study [36] recent evidence of a link between
prenatal and early-childhood lead exposure and increased
risk of criminal behavior later in life illustrated that
showed a strong association between preschool B-Pb and
subsequent crime rate trends over several decades in var-
ious countries, including France. The relationship was
characterized by best-fit lags consistent with neurobeha-
vioral damage in the first year of life and the know peak
age of offending for index crime, burglary, and violent
crime [36,41]. Several other studies support the link
between preschool lead exposure and aggressive or delin-
quent adolescent behavior and subsequent criminal vio-
lence [42,43]. We therefore estimated the costs linked to
lead-associated crime on the basis of Gould’s approach
[8]. We first obtained the total number of violent/aggres-
sive specific crimes committed in 2008 from the French
national observatory of Delinquency [44]. We then used
data from Nevin [36] to estimate the share of each of the
crimes that might be associated with lead toxicity. These
include burglaries (2.4%), robberies (0.7%), aggravated
assaults (3.1%), rape (2.7%), and murder (5.4%). The total
lead-linked crimes were computed on the basis of the
French population aged 13-60 years liable to commit a
violent act [45]. We next calculated (Bcrime) the costs
directly associated with each sort of crime and the total
cost of lead-linked crimes.
Table 2 Lifetime earning losses per year of the selected cohort according to IQ point losses within B-Pb concentration
ranges (€2008)
Blood-lead
concentrations range
(μg/L)
IQ point loss
assumptions a, b, c
Number of
children d
Number of IQ
point losses
Total Costs
(€billion)e
Lost life time earnings with a
discount factor w30(€billion)
B-Pb < 15 0 2,348,091 0 0 0
15 ≤ B-Pb < 24 1 1,648,975 1,648,975 28.6 11.8
24 ≤ B-Pb < 100 4.9 (1+3.9) 693,783 1,421,769 24.7 10.2
B-Pb ≥ 100 6.8 (1+3.9+1.9) 5,333 36,265 0.6 0.3
TOTAL 4,696,182 3,107,009 53.9 22.3
Based on a EFSA conclusions [1], b CEPA [24], c Lanphear and colleagues. [14], d InVS data [11] and e Gould [8]
Table 2 presents lifetime earning losses per year of the selected cohort according to IQ point losses within B-Pb concentration ranges. The IQ point loss assumptions
were 1, 4.9 (= 1+3.9) with 0.51 point per 10 μg/L within this range, and 6.8 (= 1+3.9 +1.9) IQ point losses per 100 μg/L within this range, from 15 to 24 μg/L, from 24 to
100 μg/L, and above 100 μg/L respectively. The loss per IQ point was estimated to be €200817, 363. Based on the equation 3 (Bearn = Bearn15-24 + Bearn24-100 + Bearn≥100),
the total lost lifetime earnings due to lead toxicity Bearn were estimated, with Bearn15-24 for increased B-Pb <24 μg/L, Bearn24-100 for B-Pb between 24 μg/L and 100 μg/L,
and Bearn≥100 for B-Pb ≥100 μg/L. We applied a discount factor w30 on the total costs and we obtained € 22.3 billion, € 10.5 billion and € 0.3 billion, respectively for the
year 2008.
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We used French data when available, and otherwise
US data in the absence of French data for direct costs of
victims and overhead costs of justice and incarceration
and for lost earnings for both criminals and victims, as
well [46,47]. All costs were adjusted by the ratio of US
and French crime rates (the US rate crime of 5.6 per
100,000 being much greater than the French rate crime,
1.7 per 100,000, in 2005) [48,49]. In this case,
Bcrime = Bcrime 100 (5)
where Bcrime are the cost estimates for B-Pb ≥100 μg/L
Intangible costs
In addition, suffering and degradation of the quality of
life associated with lead poisoning and its side effects
had to be taken into account. Intangible costs, men-
tioned Bother, while difficult to measure were taken into
account using the “pretium doloris” approach. These
costs were estimated for children with B-Pb concentra-
tions≥ 100 μg/L. The Metal Blanc factory of Bourg-
Fidèle (Ardennes administrative subdivision, North East
France), specializing in the recovery of lead from used
batteries (drum kits), was condemned for putting lives
at risk in September 2009. The judge called for
€120,000 of ‘damages and interests’ to the victims, the
cases of six families having been declared valid. The
judgment called for €8,000 for each child with B-Pb
concentrations≥ 100 μg/L [50]. We note:
Bother = Bother 100 (6)
Annual total benefits
In summary, the total benefits (avoided costs) are there-
fore given by
B = Bscreening15−24 + Bscreening24−100 + Btreatment 100
+ (Bearn15−24 + Bearn24−100 + Bearn 100)/(1 + s)
t
+ Bspec.ed 100 + Bcrime 100 + Bother 100
(7)
Final estimation included confidence intervals and a
sensitivity analysis using different key assumptions from
the American and European data, on which the calcula-
tions were based. Benefits were estimated according to
different B-Pb hypothetical threshold values, i.e. 15 μg/
L, 24 μg/L and 100 μg/L, respectively.
Abatement cost estimation
Estimates of costs associated with reduction of B-Pb
concentrations
Due to insufficient cost data related to control of lead
hazards, only preliminary estimates of cost incurred by
pollution control were performed, as indicated below.
We estimated total lead-based paint decontamination
costs, partial costs of industrial emission abatement and
lead pipe removal costs.
Total lead-based paint decontamination costs to remediate
French houses
These costs, denoted Cpaint, were calculated on the basis of
InVS [3] and INSEE data [2] on 37,382 lead-paint based
homes and using an average estimated removal cost per
home. According to the SNSPE data [22] and to Glorennec
and colleagues, [4] lead in soils and dust from the lead-
based paint in homes built before 1949 represent 74% and
16% of cases of childhood lead intoxication for blood lead
levels greater and lower than 100 μg/L, respectively. We
estimated the costs of decontaminating French houses
with lead-based paint following the data from the national
Agency of the housing environment (ANAH) scenarios
regarding elimination of lead presence. Only 37,382 homes
had to be decontaminated among about 28 million French
homes: therefore we considered that these operations
could be performed once and for-all in one year’s time.
Industrial investments costs to reduce lead exposure
The costs of investments (denoted Cind) to control
industrial lead pollution and reduce lead emissions both
in air and water were also estimated. They include tech-
nologies to recycle and reduce presence of lead in bat-
teries and in glass, abatement of diffuse emissions
through increase in the efficiency of recycling, capture
and treatment of the contaminated discharges. Invest-
ment costs were weighted per factory volumes based on
data from a National Institute for Industrial Environ-
ment and Risks - (INERIS) [51]. These were annual
costs.
Costs to eliminate water lead pipes
These costs, denoted Cwater, were estimated following
the High Council of Hygiene (CSHPF) and the French
Food Safety Agency (AFSSA) recommendations for
removing all lead pipes used in public water supply and
in household plumbing, in order to reach a lead concen-
tration of ≤10 μg/L before the end of year 2013. Cwater
based on the estimations of the European Institute Rea-
soned Management for the Environment (IEGRE) [52],
Cwater was found to be €10 billion for household pipes,
and €4 billion for public pipes. We calculated an invest-
ment plan over five years to reach the above mentioned
objective, (denoted Cpwater). Although a longer invest-
ment plan could have been chosen, we calculated the
annual costs for an investment plan over 5 years to
cover the expenses. We used ANAH estimates and
French or US data, according to which were available
[3,53-55].
Results
Annual Benefits
Direct health care costs were estimated in accordance
with equation (2) and were found to be €0.297 billion/
year as shown in table 1. Direct health costs represented
0.14% of the total French health expenditure in 2008.
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Table 1 reports the direct health cost estimates Bscreen-
ing15-24, Bscreening24-100 and Btreatment≥ 100 per B-Pb con-
centrations range.
Lost lifetime earnings ranged from €0.6 billion (Bearn≥
100) to €53.3 billion (Bearn15-24 + Bearn24-100 ) according
to B-Pb concentrations ≥ and <100 μg/L, respectively, as
presented in Table 2. Thus, B2 estimates were € 53.9 bil-
lion per year for the full B-Pb range. We note that the
loss of IQ associated with B-Pb concentrations between
15 μg/L and 100 μg/L amounted to more than 99% of
the total estimated costs. Thus, the loss of IQ would be
marginally influenced by the number underestimating of
children having a high B-Pb ≥100 μg/L. Applying the
discount factor w (w30= (1/(1.03)
30)) on lost life-time
earnings, we obtained the estimate: € 22.3 billion above
15 μg/L, € 10.5 billion above 24 μg/L and € 0.3 billion
above 100 μg/L.
For special education, the annual national cost esti-
mate Bspec.ed≥ 100 was € 14.53 million for 10% of chil-
dren with B-Pb concentrations ≥100 μg/L in need of
special education.
For deviant behavior and crime, a reduction of 10 μg/L
in preschool B-Pb ≥100 μg/L would result in 4,770 fewer
burglaries, 102 fewer robberies, and 2,206 for aggravated
assaults, 171 for rapes, and 29 for murders. In France, the
total estimated cost of lead-linked crimes (Bcrime≥ 100)
was approximately €61.8 million per year, as shown in
Table 3, this accounted for 0.3% of the total cost of crime
in 2008 [46].
Intangible costs for the population with B-Pb ≥100 μg/L
were calculated as compensations, resulting in a total cost
of €42.7 million (Bother≥ 100).
Based on these estimates, we calculated the total bene-
fit of prevented lead toxicity as the sum of avoided
costs. They included specific screening and treatment
costs of lead poisoned children (€0.3 billion), lost life-
time earnings (€53.9 billion), special education costs
(€0.145 billion), intangible costs (€0.0427 billion), and
the direct costs related to crime (€0.0618 billion). We
obtained the following total benefits for the three sensi-
tivity analyses hypothetical threshold values of 15, 24
and 100 μg/L: € 22.72 billion, € 10.72 billion and € 0.44
billion, respectively, in 2008 (Table 4). The social bene-
fits represented 98.7%, 99% and 96.5%, respectively of
the total benefits. A unit benefit was estimated per child
and per different B-Pb concentration values, as follows
€9,676, €15,334 and €82,505, respectively, for the three
threshold assumptions.
Abatement Costs
Table 5 shows that lead-based paint decontamination
costs per home ranged from € 3,562 to €9,162, with
€6,562 as the central estimates, giving total cost esti-
mates Cpaint from €245.3 [€133.1; €342.5] million in
2008. The annual industrial costs estimated Cind would
have been €28.9 million in 2008. For water lead pipes,
the total estimated costs Cwater between €4 billion and
€14 billion. We applied a 3% discounting rate for C*paint
+C*ind and an investment plan P on five years for Cwater.
Hence, on the basis on available data, annual estimates
of total costs of lead hazard control C*paint+C*ind +CP
water ranged from €0.9 billion to 2.95 € billion. Reported
per child within the cohort a unit cost was estimated to
range from €185 to €629.
Net benefits of the removal of lead-based paint in the
French houses in 2008
We first estimated total net benefit induced by the risk
factors soils and dust which contributed relatively more
to low B-Pb values than to high B-Pb levels. This net
benefit would stem from the reduction of lead hazard
exposure and of childhood lead poisoning cases induced
by this factor in respect of the costs C*paint associated
with the control of lead environmental pollution.
Table 3 The effect of developmental lead exposure on crime in France and the associated annual costs (€2008)
Crime Number of crimes per 100,000
French residents (N) a
Lead linked crimes per 100,000
French residents (N) b
Total lead linked
crimes (N)
Costs per
crime (e) c, d
Total direct
costs€million
Burglaries 497.9 11.7 4,770 2,004 9.6
Robberies 37.79 0.3 102 22,529 2.3
Aggravated
assaults
172.8 5.4 2,206 20,058 44.3
Rape 15.5 0.4 171 27,990 4.8
Murder 1.33 0.1 29 30,645 0.9
a: calculated using data from the National Observatory of the delinquency, 2009[44] b: (Nevin, 2006) by using French rate crime[36] c: calculated data from
(Arlaud, 2006)[46] d: calculated data from the US Bureau of Justice Statistics inflated to 2008[47].
Table 3 shows the effect of developmental lead exposure on crime in France and the associated annual costs. We first informed on the number of the selected
crimes per 100,000 French residents committed in 2008: 497.9 burglaries, 37.79 robberies, 172.8 aggravated assaults, 15.5 rapes and 1.33 murders. US Lead linked
crimes (with US crime rate (5.6 per 100,000)), estimated by Nevin, were adapted to the French crime rate (1.7 per 100,000): we obtained 11.7(e.g. =(38.7/5.6)*1.7)
burglaries, 0.3 robberies, 5.4 aggravated assaults, 0.4 rape and 0.1 murder for lead linked crimes per 100,000 French residents. We calculated the total lead linked
crimes for the French population aged 13-60 years. We then used French and US available data for the direct costs per crime and multiply these latter with total
lead linked crimes to obtain the total direct costs per year (€61.8 million in 2008).
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According to the hypothetical threshold values, they
ranged from € 3.78 billion, € 1.88 billion and €0.25 bil-
lion respectively for children aged 1-6 years in the 2008
cohort, as shown in Table 6.
Reported per child, and given the number of children
across hypothetical threshold values (i.e number of chil-
dren from ≥ 15 μg/L, from ≥ 24 μg/L and from ≥ 100
μg/L, respectively), the yearly estimate of net benefit per
child (2008) ranged from €1,610, €2,710 and €46,878,
respectively.
Discussion
The aim of this paper was to provide an economic eva-
luation of the health impacts of children with lead expo-
sure in France. Based on the assumption of the EFSA
report [1], that there is no threshold of lead exposure,
our study provides a range of annual benefits and partial
costs estimated in order to highlight the economic
impact for society of lead exposure reduction policies
below the conventional B-Pb screening value of 100 μg/
L. Several hypothetical threshold values for intoxication
(15, 24, 100 μg/L, respectively) were chosen following a
“what if” approach. We have no strong data to choose
levels lower than 15 μg/L but also do not assume it to be
a safe exposure level. The partial cost benefit analysis
documents a clear cost effectiveness of lead hazard con-
trol, which should result in benefits greatly superior to
the costs, as suggested by the comparison of the sum of
benefits to that of congruent costs for one year. This
study showed that by reducing childhood lead exposure,
large social benefits might be produced for the birth
cohort of 2008 (and subsequent years): € 22.72 billion, €
10.72 billion and € 0.44 billion, respectively. The benefits
were mainly due to the social avoided costs, specifically
the lost life time earnings, at exposures corresponding to
B-Pb <100 μg/L. There are some limitations to our analy-
sis, due in particular to access to figures related to
avoided costs and to costs of exposure reduction as we
will see below. This is the reason why we could not per-
form a complete CBA. Direct health costs were also
Table 4 Total Benefits and total cumulated benefits per year (in €2008 Billion)
Blood-lead concentrations range (μg/L) Bmed Bsocietal Total benefits Hypothetical threshold values (μg/L) Total cumulated benefits
15 ≤ B-Pb < 24 0.198 11.8 11.99 (1) B-Pb ≥ 15 22.72 (1+2+3)
24 ≤ B-Pb < 100 0.083 10.2 10.28 (2) B-Pb ≥ 24 10.72 (2+3)
B-Pb ≥ 100 0.016 0.44 0.44 (3) B-Pb ≥ 100 0.44
Table 4 shows the estimated total benefits ranged from blood-lead concentrations and total cumulated benefits based on three hypothetical values per year. We
first differenced the estimated medical benefits (Bmed) and the societal benefits (Bsocietal) ranged from blood-lead concentrations:
The 15-24 μg/L Bmed, the 24-100 μg/L Bmed and the ≥ 100 μg/L Bmed are the Bscreening15-24 (€0.198 Billion), the Bscreening24-100 (€0.083 billion) and the Btreatment≥
100 (€0.016 billion), respectively.
The 15-24 μg/L Bsocietal, the 24-100 μg/L Bsocietal and the ≥ 100 μg/L Bsocietal are the Bearn15-24 discounted (€11.8 billions), The Bearn24-100 discounted (€ 10.2
billions) and the Bearn≥ 100 discounted added to the Bspec.ed≥ 100 , the Bcrime≥ 100 and the Bother≥ 100 (€0.44 billion), respectively. The Bspec.ed≥ 100 equal to €0.01453
billion [(10% of the French population of children 3-6 years) ((79.8%*38,958) + (20.1%*48,255))], the Bcrime≥ 100 equal to € 0.0618 billion and the Bother≥ 100 equal
to €0.0427 billion, which are the intangible avoided costs. We estimated the total benefits (Bmed +Bsocietal) ranged from blood-lead concentrations: €11.99
billions (1), €10,28 billions (2) and € 0.44 billion (3).
We secondly estimated total cumulated benefits per year based on the three hypothetical threshold values, above 15, 24 and 100 μg/L. We obtained €22.72
billions (1+2+3), €10.72 billions (2+3) and € 0.44 billion (3), respectively.
Table 5 Costs to decontaminate French houses with lead-based paint (€2008)
Type of costs Cost1 per home Cost2 per home Cost3 per home
Global environmental survey 381a 381a 381a
Home dust analysis 30b 30b 30b
Home paint analysis 30b 30b 30b
ANAH’s assumptions 2,600c1 5,600c2 8,200c3
Housing substitutes 521d 521d 521d
Overall interventions 3,562 6,562 9,162
Total costs (€million) 133.1 245.3 342.5
a = Argeron, 1995, actualized in 2008 by INVS [3]. b = LERES, 2009[54]. c = The National Agency of the housing environment (ANAH)[53], 2010., d = Mc Laine and
colleagues.,2006, €2008[55].
Table 5 presents lead-based paint decontamination costs per home. We used French data for global environmental survey (€381) and for home dust and home
paint analysis (€30, each one). We used also the assumptions of ANAH works for estimating the removal of lead-based paint cost per home eliminating lead.
These assumptions were the following ones: Assumption 1: a 20% max rate was applied to €13,000 standard works for rehabilitating old houses <1949,
irrespective any lead-based paint intervention. Assumption 2: a 70% max rate was applied to €8,000 works of specific lead decontamination Assumption 3:
Assumptions 1 & 2 combined, i.e. the max mix of two works.
The housing substitutes, € 521, were US data based on Mc Laine analysis. Based on these data and assumptions, we calculated three overall interventions ranged
from €3,562 to €9,162 and three total lead-based paint decontamination costs ranged from €133.1 to €342 million, which were performed on the 37,382 houses
concerned, in one shot for one year.
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estimated but they were probably underestimated. Lead
exposure provokes other health impacts besides cognitive
disorders which were not assessed in this paper, such as
cardiovascular diseases and cancer that lead to premature
mortality. This would yield higher social costs than IQ
decrement alone [56]. We disregarded for instance, drug
costs and medical intervention costs such as intravenous
chelation. Among other costs, the pretium doloris calcu-
lated on the basis of €8,000 per child in the Metal Blanc
judgment was certainly underestimated, because only a
small part of the children have been compensated, while
also neglecting the psychological and economic suffering
of the family or household of the children affected. We
also estimated the need for special education to be 10%
for children with B-Pb ≥ 100 μg/L. The somewhat uncer-
tain data on crime costs suggest that the economic
impact is comparatively low, but the costs of crime and
rape were probably underestimated, because they did not
include the value of statistical life, which may be greater
than that of accidents (between €1999 0.5 to 1.5 million in
Europe and French estimations were the lowest bracket
estimate) [57,58].
They highlight the additional social consequences of
lead pollution. In regard to annual costs to invest in pol-
lution abatement, our preliminary estimates are affected
by the paucity of available data. We could not make a
complete CBA because of lack of available data on the
abatement costs, we had a very small part of the indus-
trial costs. Official data from the ministry of Environ-
ment show that the major industrial sources of lead in
France are the metals and non metallic minerals sectors
[59]. Three quarters of the 2007 emissions took place
through water, and two waste treatment facilities alone
amounted to 60% of total emissions of the ten most
emitting facilities [60]. We had also quite imprecise cost
estimates for substitution of lead pipes, whose yearly
estimates are certainly exaggerated. So far, clean-up
costs of industrial lead-contaminated sites cannot be
evaluated in France. Partial data stem from the
experience of the highly polluted MetalEurop site reme-
diated by SITA-Suez Environment, which amounted to
€28 million [61]. Unfortunately, these findings cannot be
extrapolated to the national situation. As to contami-
nated sites, we point out the need for a specific evalua-
tion. However, costs to decontaminate French houses
with lead-based paint were available. And we calculated
these costs once-for-all in one year, even if we overesti-
mated the annual expenses, they appeared to be the
most important efforts to be made in order to control
the hazard. We could express an equivalent annual cost
by using the capital recovery factor of standard interest
calculations for loans which is the appropriate conver-
sion factor. However, uncertainties remain regarding the
time horizon and the social discount rate to use. A 0.05
conversion factor between one-time cost and annual
cost is a compromise.
Some of the costs were paid within one year or paid
over no more than five years, costs would be substantially
less subsequent to that, while benefits would continue to
accrue for each new birth cohort being born during the
following years.
Our first estimates of total net benefit induced by
reducing exposure to soils and dust in respect of the
costs incurred by the decontamination of French houses
with lead-based paint highlight that policies aimed at
reducing lead exposures had an overall positive societal
and economic impact. Additional estimates of total net
benefit were performed, that considered the costs asso-
ciated with dust and soils and drinking water lead pipes
substitution. The expected health gains, according to the
different B-Pb hypothetical threshold values, were calcu-
lated to be € 3.9 to 4 billion, € 1.86-2 billion and €0.12-
0.25 billion respectively. The corresponding figures per
child range from €1,661 to €1,721, €2,666 to €2,861, and
€21,939 to €47,815, respectively. These estimates should
be considered with caution, because of the uncertainty
in the quality of data on costs of lead water pipes
removal; a specific evaluation is also needed here.
Table 6 Net benefits of the removal of lead-based paint in French houses (in €2008 Billion)
Blood-lead concentrations range
(μg/L)
Benefits Abatement
costs
Net
benefits
Hypothetical threshold values
(μg/L)
Net cumulated
benefits
15 ≤ B-Pb < 24 1.92 0.016 (0.008-0.02) 1.90 (1) B-Pb ≥ 15 3.78 (1+2+3)
24 ≤ B-Pb < 100 1.64 0.016 (0.008-0.02) 1.63 (2) B-Pb ≥ 24 1.88 (2+3)
B-Pb ≥ 100 0.33 0.074 (0.037-
0.104)
0.25 (3) B-Pb ≥ 100 0.25
Table 6 presents the net benefits of the removal of lead-based paint in French houses. Lead in soils and dust from the lead-based paint in homes built before
1949 represented 16% and 74% of cases of childhood lead intoxication for B-Pb concentration 15-100 μg/L and for B-Pb concentration≥100 μg/L, respectively.
We applied these percentages to calculate the total benefits and the total costs C*paint (with central estimates selected) of the removal of lead-based paint
ranged from blood-lead concentrations. We obtained € 1.92 billion(=€11.99billion*16%) and €0.016 billion (=(€0.2453/w30)*16%)) for the 15-24 μg/L range, €1.64
billion (=€10.28*16%) and €0.016 billion (=(€0.2453/w30)*16%)) for the 24-100 μg/L range, and € 0.33 billion (=€ 0.44 billion*74%) and (=(€0.2453/w30)*74%)) for
the ≥ 100 μg/L range, respectively. We thus calculated the net benefits of the removal of lead-based paint ranged from blood-lead concentrations: €1.90 billion
(1), € 1.63 billion (2) and € 0.25 billion (3) for B-Pb concentration 15-24, 24-100 μg/L and B-Pb concentration≥100 μg/L, respectively. Based on the three
hypothetical threshold values, above 15, 24 and 100 μg/L, we estimated also the total net benefit cumulated: €3.78 billions (1+2+3), €1.88 billion (2+3) and €0.25
billion (3), respectively.
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Various uncertainties exist in our calculations: benefits
linked to the dose-response function, and monetary
valuation of the abatement costs linked to houses reme-
diation, which yield uncertainties in the partial cost ben-
efit estimates. According to Rabl and colleagues, there is
a factor two uncertainty, both in the dose-response
function and in the monetary valuation [62,63]. Should
the scientific literature show some day evidence of lower
toxicity level values than the one we used in this sensi-
tivity analysis, the health cost figures would be substan-
tially increased.
The overall return of investments is important and
must be taken into account by the policy makers. They
are in line with several US findings that illustrate how
reduction of childhood lead exposure has a high social
benefit, in particular the studies from Schwartz [16],
Salkever [17] and Grosse and colleagues [64]. Between
1976 and 1999, Grosse et al. [64] estimated the eco-
nomic impact of the trend of reduced lead exposure
over 25 years in a cohort of children starting at 2 years
of age in 2000. The estimate cost was valued from
$110 to $319 billion (US) for the cohort each year,
comparing it as if the blood lead concentration were
that same as in 1975. Landrigan et al. [34] estimated
the total annual costs of childhood lead poisoning to
be $199743 billion in each birth cohort exposed to lead
in the US. Their methodological approach was based
on the contribution of environmental pollutants by
using an Environmentally Attributable Fraction (EAF)
model, which was estimated at 100% for lead poison-
ing. Recent studies calculated the economic impact of
childhood poisoning below100 μg/L. The most recent
major U.S. study was that of Gould [8]. It was more
comprehensive than those previously published, and
produced a CBA by comparing the estimated costs in
1996 related to cleanup of lead-containing paint in the
U.S. ($ 1 - $11 billion (US)) and secondly, by calculat-
ing the monetary benefits and social benefits by redu-
cing lead exposure for a cohort of children <6 years
($192 - $270 billion) with earning losses amounted to
87% of total avoided costs. Total net benefits amounted
to $ 181 - $ 269 billion. Therefore, a specific calcula-
tion induced by lead-based paint was not performed in
this study. Muennig et al. [65], whereas, provided infor-
mation on the benefits that might be realized if all chil-
dren in the United States had a blood lead level of less
than 10 μg/L. The net societal benefits showed
improvements in high school graduation rates and
reductions in crime would amount to $50,000 (SD,
$14,000) per child annually at a discount rate of 3%.
This would result in overall savings of approximately
$1.2 trillion (SD, $341 billion) and produce an addi-
tional 4.8 million QALYs (SD, 2 million QALYs) for
the US society as a whole.
Researchers in other European countries with preva-
lence of lead exposures similar to French figures may
use this as a guide as to undertake similar economic
assessments. Additionally, these data may motivate the
revision of the current French policies as to whether or
not to intervene in regard to lead pollution, and, in a
more general sense, revamping France’s overall policy
on reducing pollution that may be affecting children’s
development. The introduction of unleaded petrol has
greatly decreased emissions of lead in the atmosphere in
France and globally. (Paris ambient air concentrations
decreased by 97% between 1991 and 2005)[66]. The
relative benefits of this action were substantial [3] and
likely much greater than the benefits from further
reduction of B-Pb levels today. Nonetheless, much
abatement remains to be done, as other sources are only
slowly being removed, if at all. The screening of houses
for sale or rent with lead-based paint was implemented
through the 2004 Public Health Act and its stringent
policies on industrial emissions were triggered by EU
regulations. The French 2004 national environmental
health action plan has also contributed to the steady
decrease in exposure of the general population and of
its most vulnerable young segment over the last years in
France.
EFSA recommends that “work should continue to
reduce exposure to lead, from both dietary and non-
dietary sources” [1]. The major prevention campaigns
aim to reduce lead exposure to the lowest possible level
in order to protect children and childbearing age
women. The obtained benefits for exposure levels <100
μg/L in this study are in line with the EFSA recommen-
dations. They are a first step evaluation which should be
expanded and refined. Our results emphasize the sub-
stantial monetary advantages obtained from preventing
losses of a few IQ points because of lead exposures
among children. While 1-point change in Full Scale IQ
score is within the standard error of an individual’s sin-
gle measurement, it may be highly significant on a
population basis [25].
Conclusions
The primary economic benefits of policies focused on
lead exposure abatement are the further reduction of
low blood lead levels. In contrast, prevention of cases
with B-Pb >100 μg/L accounts for much lower benefits.
This is because children with milder exposures are
much more common and they still benefit from
decreased exposure, as there is no known safe level of
lead exposure. Lead toxicity is still a serious public
health issue, despite the present low prevalence of unac-
ceptably high B-Pb concentrations. Public policies to
prevent lead exposure will reduce future medical
expenses and the reduce the burden on special
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education classes. More importantly, they will also
increase the productivity of children during their adult
lives. Our CBA results suggest that overall reduction of
costs due to toxicity can be achieved by further control
of major contact media, including food, through diffu-
sion of lead in the environment from industrial releases
and also by further control of residential sources (leaded
paint, deteriorated housing, old water pipes). In addition
to abating the burden of developmental impairment in
general, these policies will also help to reduce health
disparities. This objective calls for prioritized policies
focused on the most highly exposed communities and
individuals. This combined strategy is a policy issue that
our data aim to inspire. Yet, additional documentation
of the B-Pb values for further evaluation is needed. A
more thorough evaluation of the marginal costs of the
measures to be taken is also needed in order to balance
lead exposure abatement options.
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